RYTM
Rhythm Pharmaceuticals, Inc. Health Care Pharmaceutical Preparations Russell 3000
$92.57Close
$6.2BMarket cap
$75.82 – $117.6252-week range
Nov 3, 2026Next report · before the open
Highlights
Cautions
- Not in an uptrend 2 of 8 trend conditions
- Lagging the market RS 32 · weaker than 68% of stocks over 12 months
- Results soon Nov 3, 2026, in 2 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
21%
1wk
up 3.7%
price change
1mo
down 2.8%
price change
12-month return
down 17%
market up 11% ·
its own down 30%
F-score
5 / 9
Mixed
Altman Z
13.80
Low risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
44.7×
price / book
Earnings yield
down 3.1%
EBIT / enterprise value
Cheaper than
12%
of the market · expensive
Revenue growth
up 46%
year on year
EPS growth
—
latest quarter
Sales growth
up 47%
latest quarter · -37 pts
ROE
0%
return on equity
Free cash margin
down 61%
-$116.6M FCF
D/E
0.73
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
- not yet profitable on its assets
- operating cash flow is negative
- profits not fully backed by cash
- issued more shares
- profitability improving
- reduced long-term debt
- short-term liquidity improved
- gross margin widened
- assets working harder
Repair signals
- Long-term debt down 7% ($0.1B → $0.1B)
Trade setup
ATR%
3.5%
$3.27 a day · 2×ATR $86.04
RS
32 / 99
vs the universe
Trend
2 / 8
trend template
Relative volume
0.7×
vs 50-day average
Up/down volume
0.81
50 sessions
Implied move
—
no option chain · report Nov 3, 2026
Trend template · 2 of 8
- 150-day average above the 200-day: passes
- Within 25% of the 52-week high: passes
Screen verdict
Did not qualify for any screen.
Warning signs
- Shareholders diluted The share count rose 7.7% over the year, from 62m to 67m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 4, 2026
Results reaction
Aug 4, 2026+6% vs market2 sessions after results
Financials
- Gross 90%
- Net -0%
- Free cash -61%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $3.2M | $23.6M | $77.4M | $130.1M | $189.8M |
| Gross margin | — | 81% | 91% | 88% | 90% | 90% |
| Operating income | -$136.6M | -$170.1M | -$179.2M | -$184.4M | -$265.5M | -$192.0M |
| Net income | -$134.0M | -$69,612 | -$181,119 | -$184,678 | -$260,602 | -$196,539 |
| Net margin | — | -2% | -1% | -0% | -0% | -0% |
| Earnings per share | -$3.04 | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -$0.00 |
| Free cash flow | -$122.2M | -$146.4M | -$173.7M | -$136.2M | -$113.9M | -$116.6M |
| Free cash margin | — | -4643% | -735% | -176% | -88% | -61% |
| Cash | $100.9M | $59.2M | $127.7M | $60.1M | $89.1M | $54.3M |
| Long-term debt | — | — | — | $106.1M | $108.3M | $100.9M |
| Shareholders' equity | $166.5M | $284.2M | $264.3M | $169.8M | $21.7M | $139.1M |
| Shares outstanding | 44.24m | 50.28m | 56.61m | 59.43m | 62.39m | 67.21m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 4, 2026 | Quarterly ↗ | Jun 30, 2026 | 35d |
| May 5, 2026 | Quarterly ↗ | Mar 31, 2026 | 35d |
| Feb 26, 2026 | Annual ↗ | Dec 31, 2025 | 57d |
| Nov 4, 2025 | Quarterly ↗ | Sep 30, 2025 | 35d |
| Aug 5, 2025 | Quarterly ↗ | Jun 30, 2025 | 36d |
| May 7, 2025 | Quarterly ↗ | Mar 31, 2025 | 37d |
| Feb 28, 2025 | Annual ↗ | Dec 31, 2024 | 59d |
| Nov 6, 2024 | Quarterly ↗ | Sep 30, 2024 | 37d |
| Aug 6, 2024 | Quarterly ↗ | Jun 30, 2024 | 37d |
| May 7, 2024 | Quarterly ↗ | Mar 31, 2024 | 37d |
| Feb 29, 2024 | Annual ↗ | Dec 31, 2023 | 60d |
| Nov 8, 2023 | Quarterly ↗ | Sep 30, 2023 | 39d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 4, 2026 | Results · Regulation FD · Other events ↗ |
| Jun 25, 2026 | Shareholder vote ↗ |
| Jun 15, 2026 | Regulation FD · Other events ↗ |
| May 5, 2026 | Results ↗ |
| Apr 3, 2026 | Director or officer change · Regulation FD ↗ |
| Mar 26, 2026 | Regulation FD · Other events ↗ |
| Mar 20, 2026 | Regulation FD · Other events ↗ |
| Mar 16, 2026 | Regulation FD · Other events ↗ |
| Mar 2, 2026 | Regulation FD · Other events ↗ |
| Feb 26, 2026 | Results ↗ |
| Jan 9, 2026 | Results · Regulation FD · Other events ↗ |
| Dec 19, 2025 | Director or officer change ↗ |